GALMED PHARMACEUTICALS LTD (GLMD) Stock Cash Flow
NASDAQ:GLMD - IL0011313900 - Common Stock
1.39 USD
-0.02 (-1.42%)
1.4092 USD
+0.02 (+1.38%)
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -7.35M | -7.52M | -6.91M | -17.87M | -32.47M | |||
| Depreciation Amortization | 73.00K | 83.00K | 31.00K | 40.00K | 40.00K | |||
| Change In Working Capital | -149.00K | -728.00K | 132.00K | -2.45M | -2.45M | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 2.21M | 2.28M | 612.00K | 1.78M | 1.98M | |||
| OPERATING CASH FLOW | -5.22M | -5.88M | -6.14M | -18.50M | -32.89M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | 0.00 | 0.00 | -10.00K | |||
| Other Investing Activity | -1.77M | -1.11M | 800.00K | 17.57M | 11.47M | |||
| INVESTING CASH FLOW | -1.77M | -1.11M | 800.00K | 17.56M | 11.46M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | N/A | 8.79M | 6.18M | 70.00K | 17.37M | |||
| FINANCING CASH FLOW | N/A | 8.79M | 6.18M | 70.00K | 17.37M | |||
| CHANGE IN CASH | 3.31M | 1.79M | 848.00K | -870.00K | -4.06M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -5.22M | -5.88M | -6.14M | -18.50M | -32.89M | |||
| Capital Expenditure | N/A | N/A | 0.00 | 0.00 | -10.00K | |||
| FREE CASH FLOW | -5.22M | -5.88M | -6.14M | -18.50M | -32.90M | |||
All data in USD